Fourth-quarter adjusted profit per share is expected to fall 48% at the midpoint for FMC
FMC Corporation reported Q3 2026 revenue of $639M, down $106M YoY, with a GAAP net loss of $1.5B. Adjusted EBITDA was -$672M, and adjusted loss per share was $5.30. The company expects Q4 revenue of $1.04B, adjusted EBITDA of $210M, and adjusted EPS of $0.56. Full-year free cash flow is projected to be negative $350M. The declines are attributed to commercial actions and weaker demand.
How this was made
The 30-second read
Why it matters
The company reports third-quarter results reflecting the actions’ financial impact and updates Q4 and full-year outlook, including a sharp midpoint decline in adjusted EPS and a continued negative free-cash-flow outlook.
Market read
Traders get a concrete earnings and cash-flow guidance reset for Q4 and full-year 2026, with the driver explicitly tied to ongoing commercial actions and weaker-than-expected demand.
What to watch
Implementation is expected to occur over the next three quarters, so the market may be underweighting the timing risk of when pricing and inventory movement benefits offset the cash and earnings headwinds.
Background
FMC previously announced commercial actions on Oct. 15 to address elevated channel inventory values and improve product movement to growers.
Ticker impact
FMC cut Q4 adjusted EPS guidance to a midpoint implying a 48% decline, citing updated expectations after commercial actions and weaker demand.
Likely downward pressure as traders reprice 2026 earnings and free-cash-flow trajectory after the guidance cut.
The article provides specific Q4 adjusted EPS and full-year free cash flow outlook changes, directly tied to the company’s ongoing commercial actions and demand weakness.
Market effects
Signals stress in agricultural inputs demand and channel inventory management, which can weigh on sentiment for crop-protection peers with similar inventory/rebate models.
No specific regional shock beyond FMC’s disclosed EMEA and other regional revenue declines.
Limited broader macro linkage; primarily company-specific guidance and execution risk.
Counterpoint
The commercial actions are framed as inventory correction and model transition, so the near-term earnings hit could be a one-time drag with improving 2027 fundamentals.
Key entities
- companyFMC Corporation
Agricultural sciences company providing crop protection solutions; subject of the guidance and commercial-actions update.
